{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:06:34Z","timestamp":1793135194798,"version":"4.5.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The molecular mechanisms of \u03b2-lactam resistance mediated by AmpC hyperproduction in natural strains of\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    were investigated in a collection of 10 isogenic, ceftazidime-susceptible and -resistant pairs of isolates, each sequentially recovered from a different intensive care unit patient treated with \u03b2-lactams. All 10 ceftazidime-resistant mutants hyperproduced AmpC (\u03b2-lactamase activities were 12- to 657-fold higher than those of the parent strains), but none of them harbored mutations in\n                    <jats:italic>ampR<\/jats:italic>\n                    or the\n                    <jats:italic>ampC-ampR<\/jats:italic>\n                    intergenic region. On the other hand, six of them harbored inactivating mutations in\n                    <jats:italic>ampD<\/jats:italic>\n                    : four contained frameshift mutations, one had a C\u2192T mutation, creating a premature stop codon, and finally, one had a large deletion, including the complete\n                    <jats:italic>ampDE<\/jats:italic>\n                    region. Complementation studies revealed that only three of the six\n                    <jats:italic>ampD<\/jats:italic>\n                    mutants could be fully transcomplemented with either\n                    <jats:italic>ampD<\/jats:italic>\n                    - or\n                    <jats:italic>ampDE<\/jats:italic>\n                    -harboring plasmids, whereas one of them could be transcomplemented only with\n                    <jats:italic>ampDE<\/jats:italic>\n                    and two of them (including the mutant with the deletion of the\n                    <jats:italic>ampDE<\/jats:italic>\n                    region and one with an\n                    <jats:italic>ampD<\/jats:italic>\n                    frameshift mutation leading to an\n                    <jats:italic>ampDE<\/jats:italic>\n                    -fused open reading frame) could not be fully transcomplemented with any of the plasmids. Finally, one of the four mutants with no mutations in\n                    <jats:italic>ampD<\/jats:italic>\n                    could be transcomplemented, but only with\n                    <jats:italic>ampDE<\/jats:italic>\n                    . Although the inactivation of AmpD is found to be the most frequent mechanism of AmpC hyperproduction in clinical strains, our findings suggest that for certain types of mutations, AmpE plays an indirect role in resistance and that there are other unknown genes involved in AmpC hyperproduction, with at least one of them apparently located close to the\n                    <jats:italic>ampDE<\/jats:italic>\n                    operon.\n                  <\/jats:p>","DOI":"10.1128\/aac.49.11.4733-4738.2005","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T12:37:59Z","timestamp":1130330279000},"page":"4733-4738","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":165,"title":["Molecular Mechanisms of \u03b2-Lactam Resistance Mediated by AmpC Hyperproduction in\n                    <i>Pseudomonas aeruginosa<\/i>\n                    Clinical Strains"],"prefix":"10.1128","volume":"49","author":[{"given":"Carlos","family":"Juan","sequence":"first","affiliation":[{"name":"Servicio de Microbiologi\u0301a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u0301a D.","family":"Macia\u0301","sequence":"additional","affiliation":[{"name":"Servicio de Microbiologi\u0301a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Gutie\u0301rrez","sequence":"additional","affiliation":[{"name":"Servicio de Microbiologi\u0301a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Vidal","sequence":"additional","affiliation":[{"name":"Unidad de Secuenciacio\u0301n, Hospital Son Dureta, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301 L.","family":"Pe\u0301rez","sequence":"additional","affiliation":[{"name":"Servicio de Microbiologi\u0301a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[{"name":"Servicio de Microbiologi\u0301a"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.11.3406-3411.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1380"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.4.1339-1346.2000"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.6.1379"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.10.2113"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/j.1875-9114.1995.tb04366.x","volume":"15","year":"1995","unstructured":"Fish, D. N., S. C. Piscitelli, and L. H. Danziger. 1995. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy15:279-291.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/26.2.247"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.60.3.539-574.1996"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.9.3573-3575.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1994.tb07159.x"},{"key":"e_1_3_2_13_2","first-page":"709","volume":"5","year":"1986","unstructured":"Honore, N., M. H. Nicolas, and S. T. Cole. 1986. Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J.5:709-714.","journal-title":"EMBO J."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1989.tb00262.x"},{"key":"e_1_3_2_15_2","unstructured":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.11.1946"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.561-567.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.12.3296"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.583-589.2000"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.169.5.1923-1928.1987"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.171.7.3746-3753.1989"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013107"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.557"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/338782"},{"key":"e_1_3_2_25_2","first-page":"315","volume":"111","year":"1993","unstructured":"Lodge, J., S. Busby, and L. Piddock. 1993. Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC promoter. FEMS Microbiol. Lett.111:315-320.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.2.194-222.2002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.2_suppl.373S"},{"key":"e_1_3_2_28_2","first-page":"1464","volume":"102","year":"2001","unstructured":"Nagaki, M., S. Shimura, Y. Tanno, T. Ishibashi, H. Sasaki, and T. Takishima. 2001. Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis. Chest102:1464-1469.","journal-title":"Chest"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.1995.1.111"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/107662903322762743"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.862"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5469.1251"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.24.10509"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2494"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/35023079"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13644-6"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)90237-2"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/25.6.891","volume":"25","year":"1990","unstructured":"Wu, P. J., and D. M. Livermore. 1990. Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other beta-lactams. J. Antimicrob. Chemother.25:891-902.","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.11.4733-4738.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.11.4733-4738.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T02:50:20Z","timestamp":1706669420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.11.4733-4738.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1128\/AAC.49.11.4733-4738.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.11.4733-4738.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"2005-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}